{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T10:25:26Z","timestamp":1774952726069,"version":"3.50.1"},"reference-count":62,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1097\/aci.0b013e328357b4a2","type":"journal-article","created":{"date-parts":[[2012,8,21]],"date-time":"2012-08-21T14:18:18Z","timestamp":1345558698000},"page":"548-554","source":"Crossref","is-referenced-by-count":17,"title":["Corneal angiogenesis and lymphangiogenesis"],"prefix":"10.1097","volume":"12","author":[{"given":"Birgit","family":"Regenfu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Bock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus","family":"Cursiefen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-18-20210128","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/386671a0","article-title":"Mechanisms of angiogenesis.","volume":"386","author":"Risau","year":"1997","journal-title":"Nature"},{"key":"R2-18-20210128","first-page":"52","article-title":"Angiogenesis in the female reproductive system.","volume":"35-","author":"Augustin","year":"2005","journal-title":"Exs"},{"key":"R4-18-20210128","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/ar.1092160207","article-title":"Scanning electron microscope study of the developing microvasculature in the postnatal rat lung.","volume":"216","author":"Caduff","year":"1986","journal-title":"Anat Rec"},{"issue":"Suppl","key":"R5-18-20210128","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1679\/aohc.55.Suppl_65","article-title":"Intussusceptive microvascular growth: a common alternative to capillary sprouting.","volume":"55","author":"Patan","year":"1992","journal-title":"Arch Histol Cytol"},{"key":"R6-18-20210128","first-page":"33","article-title":"New insights into intussusceptive angiogenesis.","volume":"17-","author":"Djonov","year":"2005","journal-title":"Exs"},{"key":"R7-18-20210128","first-page":"23","article-title":"A new mechanism of blood vessel growth: hope for new treatment strategies.","volume":"8","author":"Kilarski","year":"2009","journal-title":"Discov Med"},{"key":"R8-18-20210128","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1172\/JCI23874","article-title":"Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages.","volume":"115","author":"Maruyama","year":"2005","journal-title":"J Clin Invest"},{"key":"R9-18-20210128","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.ajpath.2011.01.011","article-title":"VAP-1-mediated M2 macrophage infiltration underlies IL-1beta- but not VEGF-A-induced lymph- and angiogenesis.","volume":"178","author":"Nakao","year":"2011","journal-title":"Am J Pathol"},{"key":"R10-18-20210128","doi-asserted-by":"crossref","first-page":"11405","DOI":"10.1073\/pnas.0506112103","article-title":"Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision.","volume":"103","author":"Cursiefen","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R11-18-20210128","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nature05249","article-title":"Corneal avascularity is due to soluble VEGF receptor-1.","volume":"443","author":"Ambati","year":"2006","journal-title":"Nature"},{"key":"R12-18-20210128","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1167\/iovs.03-1380","article-title":"Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival.","volume":"45","author":"Cursiefen","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R13-18-20210128","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archopht.126.1.71","article-title":"Promotion of graft survival by vascular endothelial growth factor A neutralization after high-risk corneal transplantation.","volume":"126","author":"Bachmann","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"R14-18-20210128","doi-asserted-by":"crossref","first-page":"535","DOI":"10.4049\/jimmunol.0903180","article-title":"Cutting edge: lymphatic vessels, not blood vessels, primarily mediate immune rejections after transplantation.","volume":"184","author":"Dietrich","year":"2010","journal-title":"J Immunol"},{"key":"R15-18-20210128","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1167\/iovs.11-8668","article-title":"Vascular endothelial growth factor-C promotes alloimmunity by amplifying antigen-presenting cell maturation and lymphangiogenesis.","volume":"53","author":"Hajrasouliha","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R16-18-20210128","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1582-4934.2009.00941.x","article-title":"A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use.","volume":"14","author":"Wu","year":"2010","journal-title":"J Cell Mol Med"},{"key":"R17-18-20210128","doi-asserted-by":"crossref","first-page":"e33576","DOI":"10.1371\/journal.pone.0033576","article-title":"Morpholino-mediated increase in soluble Flt-1 expression results in decreased ocular and tumor neovascularization.","volume":"7","author":"Owen","year":"2012","journal-title":"PloS One"},{"key":"R18-18-20210128","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1167\/iovs.11-8391","article-title":"Vascular endothelial growth factor receptor 1 morpholino decreases angiogenesis in a murine corneal suture model.","volume":"53","author":"Cho","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R19-18-20210128","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1167\/iovs.06-0570","article-title":"Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis.","volume":"48","author":"Bock","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R20-18-20210128","doi-asserted-by":"crossref","first-page":"8718","DOI":"10.1167\/iovs.11-7871","article-title":"Corneal penetration of topical and subconjunctival bevacizumab.","volume":"52","author":"Dastjerdi","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R21-18-20210128","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00417-009-1099-1","article-title":"Short- and long-term safety profile and efficacy of topical bevacizumab (Avastin) eye drops against corneal neovascularization.","volume":"247","author":"Koenig","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R23-18-20210128","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1167\/iovs.07-1129","article-title":"Safety profile of topical VEGF neutralization at the cornea.","volume":"50","author":"Bock","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R24-18-20210128","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1167\/iovs.09-4937","article-title":"The inhibitory effects of bevacizumab eye drops on NGF expression and corneal wound healing in rats.","volume":"51","author":"Kim","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R25-18-20210128","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1167\/iovs.07-1418","article-title":"Vascular endothelial growth factor mediates corneal nerve repair.","volume":"49","author":"Yu","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R26-18-20210128","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jtos.2012.01.005","article-title":"Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin).","volume":"10","author":"Stevenson","year":"2012","journal-title":"Ocul Surf"},{"key":"R27-18-20210128","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archophthalmol.2011.42","article-title":"Suppression of inflammatory corneal lymphangiogenesis by application of topical corticosteroids.","volume":"129","author":"Hos","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"R28-18-20210128","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1097\/ICO.0b013e318213f39f","article-title":"Glucocorticoids suppress corneal lymphangiogenesis.","volume":"30","author":"Steele","year":"2011","journal-title":"Cornea"},{"key":"R29-18-20210128","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1124\/jpet.108.147496","article-title":"Potent in vivo antiangiogenic effects of GS-101 (5-TATCCGGAGGGCTCGCCATGCTGCT-3), an antisense oligonucleotide preventing the expression of insulin receptor substrate-1.","volume":"329","author":"Al-Mahmood","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"R30-18-20210128","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1167\/iovs.11-9064","article-title":"Antiangiogenic activity of aganirsen in nonhuman primate and rodent models of retinal neovascular disease after topical administration.","volume":"53","author":"Cloutier","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R31-18-20210128","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.ophtha.2009.04.016","article-title":"GS-101 antisense oligonucleotide eye drops inhibit corneal neovascularization: interim results of a randomized phase II trial.","volume":"116","author":"Cursiefen","year":"2009","journal-title":"Ophthalmology"},{"key":"R32-18-20210128","doi-asserted-by":"crossref","first-page":"5778","DOI":"10.1167\/iovs.10-6816","article-title":"Blockade of insulin receptor substrate-1 inhibits corneal lymphangiogenesis.","volume":"52","author":"Hos","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R33-18-20210128","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nm.2018","article-title":"Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth.","volume":"15","author":"Albuquerque","year":"2009","journal-title":"Nat Med"},{"key":"R34-18-20210128","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1167\/iovs.03-0940","article-title":"Roles of thrombospondin-1 and -2 in regulating corneal and iris angiogenesis.","volume":"45","author":"Cursiefen","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R35-18-20210128","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1084\/jem.20092277","article-title":"Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes.","volume":"208","author":"Cursiefen","year":"2011","journal-title":"J Exp Med"},{"key":"R36-18-20210128","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.2353\/ajpath.2010.090829","article-title":"Endogenous angiogenesis inhibitor vasohibin1 exhibits broad-spectrum antilymphangiogenic activity and suppresses lymph node metastasis.","volume":"176","author":"Heishi","year":"2010","journal-title":"Am J Pathol"},{"key":"R37-18-20210128","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1096\/fasebj.14.7.871","article-title":"Genetic heterogeneity of angiogenesis in mice.","volume":"14","author":"Rohan","year":"2000","journal-title":"FASEB J"},{"key":"R38-18-20210128","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1096\/fj.03-0246fje","article-title":"Genetic loci that control vascular endothelial growth factor-induced angiogenesis.","volume":"17","author":"Rogers","year":"2003","journal-title":"FASEB J"},{"key":"R39-18-20210128","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1096\/fj.03-1241com","article-title":"Genetic loci that control the angiogenic response to basic fibroblast growth factor.","volume":"18","author":"Rogers","year":"2004","journal-title":"FASEB J"},{"key":"R40-18-20210128","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1096\/fj.09-134056","article-title":"Lymphangiogenesis and angiogenesis: concurrence andor dependence Studies in inbred mouse strains.","volume":"24","author":"Nakao","year":"2010","journal-title":"FASEB J"},{"key":"R41-18-20210128","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2353\/ajpath.2010.090794","article-title":"Genetic heterogeneity of lymphangiogenesis in different mouse strains.","volume":"177","author":"Regenfuss","year":"2010","journal-title":"Am J Pathol"},{"key":"R42-18-20210128","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1167\/iovs.11-8010","article-title":"The maintenance of lymphatic vessels in the cornea is dependent on the presence of macrophages.","volume":"53","author":"Maruyama","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R43-18-20210128","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0966-3274(98)80041-5","article-title":"Fate of orthotopic corneal allografts in C57BL6 mice.","volume":"6","author":"Yamada","year":"1998","journal-title":"Trans Immunol"},{"key":"R44-18-20210128","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1167\/iovs.10-6080","article-title":"Genetic association with response to intravitreal ranibizumab in patients with neovascular AMD.","volume":"52","author":"Kloeckener-Gruissem","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R45-18-20210128","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1200\/JCO.2008.16.1612","article-title":"Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100.","volume":"26","author":"Schneider","year":"2008","journal-title":"J Clin Oncol: Official J Am Soc Clin Oncol"},{"key":"R46-18-20210128","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2217\/14622416.8.1.49","article-title":"Vascular endothelial growth factor pharmacogenetics: a new perspective for antiangiogenic therapy.","volume":"8","author":"Pasqualetti","year":"2007","journal-title":"Pharmacogenomics"},{"key":"R47-18-20210128","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.bbrc.2005.05.167","article-title":"Functional VEGF C-634G polymorphism is associated with development of diabetic macular edema and correlated with macular retinal thickness in type 2 diabetes.","volume":"333","author":"Awata","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"R48-18-20210128","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/ncponc0026","article-title":"Targeting angiogenesis in cancer: clinical development of bevacizumab.","volume":"1","author":"Kerr","year":"2004","journal-title":"Nat Clin Prac Oncol"},{"issue":"Suppl 1","key":"R49-18-20210128","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1517\/13543781003732701","article-title":"Pharmacogenetics in breast cancer: focus on hormone therapy, taxanes, trastuzumab and bevacizumab.","volume":"19","author":"Longo","year":"2010","journal-title":"Exp Opin Invest Drugs"},{"key":"R50-18-20210128","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0198-8859(99)00132-9","article-title":"Novel polymorphisms in the promoter and 5 UTR regions of the human vascular endothelial growth factor gene.","volume":"60","author":"Brogan","year":"1999","journal-title":"Hum Immunol"},{"key":"R51-18-20210128","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1093\/hmg\/ddl238","article-title":"VEGF polymorphisms are associated with neovascular age-related macular degeneration.","volume":"15","author":"Churchill","year":"2006","journal-title":"Hum Mol Genet"},{"key":"R52-18-20210128","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1167\/iovs.07-1383","article-title":"VEGF polymorphisms are associated with severity of diabetic retinopathy.","volume":"49","author":"Churchill","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R53-18-20210128","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.yexcr.2005.10.021","article-title":"The effect of genetic diversity on angiogenesis.","volume":"312","author":"Rogers","year":"2006","journal-title":"Exp Cell Res"},{"key":"R54-18-20210128","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000048807","article-title":"Genomic structures of the human angiopoietins show polymorphism in angiopoietin-2.","volume":"94","author":"Ward","year":"2001","journal-title":"Cytogenet Cell Genet"},{"key":"R55-18-20210128","doi-asserted-by":"crossref","first-page":"20069","DOI":"10.1074\/jbc.M800223200","article-title":"Influences of the N700S thrombospondin-1 polymorphism on protein structure and stability.","volume":"283","author":"Carlson","year":"2008","journal-title":"J Bio Chem"},{"key":"R56-18-20210128","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1161\/01.CIR.0000089085.76320.4E","article-title":"Thrombospondin-4 and its variants: expression and differential effects on endothelial cells.","volume":"108","author":"Stenina","year":"2003","journal-title":"Circulation"},{"key":"R57-18-20210128","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.ophtha.2010.01.030","article-title":"Association of age-related macular degeneration with polymorphisms in vascular endothelial growth factor and its receptor.","volume":"117","author":"Galan","year":"2010","journal-title":"Ophthalmology"},{"key":"R58-18-20210128","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.2337\/db07-0376","article-title":"Multiple variants in vascular endothelial growth factor (VEGFA) are risk factors for time to severe retinopathy in type 1 diabetes: the DCCTEDIC genetics study.","volume":"56","author":"Al-Kateb","year":"2007","journal-title":"Diabetes"},{"key":"R59-18-20210128","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.2337\/diabetes.51.5.1635","article-title":"A common polymorphism in the 5-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes.","volume":"51","author":"Awata","year":"2002","journal-title":"Diabetes"},{"key":"R60-18-20210128","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1182\/blood-2010-02-267427","article-title":"Blood vessel endothelial VEGFR-2 delays lymphangiogenesis: an endogenous trapping mechanism links lymph- and angiogenesis.","volume":"117","author":"Nakao","year":"2011","journal-title":"Blood"},{"key":"R61-18-20210128","doi-asserted-by":"crossref","first-page":"11658","DOI":"10.1073\/pnas.0404272101","article-title":"Dose-dependent response of FGF-2 for lymphangiogenesis.","volume":"101","author":"Chang","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R62-18-20210128","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/ICO.0b013e31823f8b5a","article-title":"b-FGF induces corneal blood and lymphatic vessel growth in a spatially distinct pattern.","volume":"31","author":"Hajrasouliha","year":"2012","journal-title":"Cornea"},{"key":"R63-18-20210128","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1089\/lrb.2011.0005","article-title":"Increased lymphangiogenesis and hemangiogenesis in infant cornea.","volume":"9","author":"Yuen","year":"2011","journal-title":"Lymph Res Biol"},{"key":"R64-18-20210128","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1167\/iovs.09-4505","article-title":"Differential distribution of blood and lymphatic vessels in the murine cornea.","volume":"51","author":"Ecoiffier","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Current Opinion in Allergy & Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ACI.0b013e328357b4a2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T15:18:35Z","timestamp":1714317515000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00130832-201210000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":62,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/aci.0b013e328357b4a2","relation":{},"ISSN":["1528-4050"],"issn-type":[{"value":"1528-4050","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}